Search the GHTC website

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

August 22, 2013 by Kim Lufkin

In this regular feature on Breakthroughs, we highlight some of the most interesting reads in global health research from the past week.

The United Kingdom’s Department for International Development has announced it is investing £138 million—or approximately $215 million—over the next five years into nine public-private partnerships to support the development of new drugs, vaccines, insecticides, diagnostic tools, and microbicides.

In the newest issue of Frontlines, the online magazine from the US Agency for International Development, the agency looks back at some of its most successful projects—several of which involved investments in innovation, research, and development.

Belgian scientists have taken early steps toward the development of a new drug to treat sleeping sickness.

Ahead of the upcoming United Nations General Assembly next month, Secretary-General Ban Ki-moon has released a report with updates on the Millennium Development Goals and next steps.

The Global Post reports on an in-depth research project examining diarrheal disease in the developing world, which could be used to help develop new vaccines and other tools against childhood diarrhea.

About the author

Kim LufkinGHTC

Kim Lufkin is a communications officer at GHTC.